1,2-Dichloroethane, min. 99%, for synthesis, 2.5 L, glass packaging

2-Oxo-1,2,3,4-tetrahydro-quinoline-4-carboxylic acid, 95.0%, 250mg

4-(Pyridin-4-yl)but-3-yn-1-ol, 95.0%, 5g

2-Bromo-9,10-di(2-naphthyl)anthracene>98.0%(HPLC)1g

7-Chloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine, 95.0%, 250mg

3-(aminomethyl)-5-chloropyridin-2-amine, 97%, 1g

4-Aminobenzenethiol>98.0%(GC)5g

2-butyl-3-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one, 95%, 5g

Sodium 2-(2,4-dichlorophenoxy)acetate hydrate, 95.0%, 25g

tert-Butyl 4-(3-iodo-1H-indazol-6-yl)piperazine-1-carboxylate, 95.0%, 250mg

4-Methylpyridine-3-boronic acid, 97.0%, 100g

4-Bromo-2,5-difluorophenol, 97.0%, 100g

(2E)-1-(2,4-dimethoxyphenyl)-3-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 2g